ETF overview
This exchange-traded fund (ETF) operates with an active management approach, mainly allocating capital to large-capitalization companies. Its investment decisions are guided by a proprietary system engineered to identify businesses poised for significant profitability. The core objective is to capture the full range of their valuation appreciation, particularly as their price-to-earnings ratio expands. Under ordinary market conditions, at least four-fifths of the fund's total assets will be invested in equity securities.
Fund facts
- Expense ratio
- 0.65%
- Fund assets
- 167.33M USD (all share classes)
- Issuer
- Faith Investor Services
- Inception date
- Dec 20, 2024
- Number of holdings
- 50
Breakdown
Holdings (50)
| Name | Ticker | Weight |
|---|---|---|
| NVIDIA Corp | NVDA | 7.14% |
| First American Treasury Obligations Fund 01/01/2040 | 5.75% | |
| Eli Lilly & Co | LLY | 4.49% |
| AbbVie Inc | ABBV | 3.96% |
| Linde PLC | LIN | 3.70% |
| Cisco Systems Inc | CSCO | 2.95% |
| Gilead Sciences Inc | GILD | 2.75% |
| Broadcom Inc | AVGO | 2.70% |
| Coca-Cola Consolidated Inc | COKE | 2.55% |
| Amgen Inc | AMGN | 2.51% |
| and 37 more | ||
Similar ETFs
- AGF U.S. Market Neutral Anti-Beta FundBTAL · Overlap 32% · Expense ratio 1.65%
Overlap is the share of assets the two funds hold in common.
Historical returns do not guarantee future returns. This is not investment advice.
- Expense ratio
- 0.65%
- Fund assets
- 167.33M USD (all share classes)
- Issuer
- Faith Investor Services
- Inception date
- Dec 20, 2024
- Number of holdings
- 50
| Name | Ticker | Weight |
|---|---|---|
| NVIDIA Corp | NVDA | 7.14% |
| First American Treasury Obligations Fund 01/01/2040 | 5.75% | |
| Eli Lilly & Co | LLY | 4.49% |
| AbbVie Inc | ABBV | 3.96% |
| Linde PLC | LIN | 3.70% |
| Cisco Systems Inc | CSCO | 2.95% |
| Gilead Sciences Inc | GILD | 2.75% |
| Broadcom Inc | AVGO | 2.70% |
| Coca-Cola Consolidated Inc | COKE | 2.55% |
| Amgen Inc | AMGN | 2.51% |
| and 37 more | ||
This exchange-traded fund (ETF) operates with an active management approach, mainly allocating capital to large-capitalization companies. Its investment decisions are guided by a proprietary system engineered to identify businesses poised for significant profitability. The core objective is to capture the full range of their valuation appreciation, particularly as their price-to-earnings ratio expands. Under ordinary market conditions, at least four-fifths of the fund's total assets will be invested in equity securities.
- AGF U.S. Market Neutral Anti-Beta FundBTAL · Overlap 32% · Expense ratio 1.65%
Overlap is the share of assets the two funds hold in common.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free